Apr 21 Pepper Hamilton Life Sciences Speaker Series
Title: From Conception to Market: Perspectives on Drug Discovery & Development
Speaker: Dr. Edward M. Scolnick
Identifying and moving a lead candidate from conception to the market is the biggest challenge a biotech or pharmaceutical company will undertake. Dr. Edward M. Scolnick, who presided over Merck & Co.’s research and development activities for almost 20 years helped develop and bring to market therapies that have helped millions of patients worldwide.
Join Pepper attorney Daniel M. Scolnick as he sits down with Dr. Scolnick, to discuss his experiences developing and bringing therapeutics to the market.
Whether you are a CEO, CSO, or other executive in the pharmaceutical industry this discussion will provide you with a unique opportunity to hear from Dr. Scolnick about his experiences in the trenches of drug development and ask him questions. The topics covered will include:
Boston Marriott Cambridge
Cambridge MA 02142
Date and Time
Begins: 04/21/2016 08:00 AM
Ends: 04/21/2016 09:30 AM
Dr. Edward M. Scolnick is a core member of the Broad Institute of MIT and Harvard and chief scientist of Broads Stanley Center for Psychiatric Research.
Scolnick joined the institute in 2004 to spearhead a major research effort in psychiatric disease and in 2007 became the director of Broads Psychiatric Disease Program and founding director of the institutes newly launched Stanley Center for Psychiatric Research. Scolnick served as the Stanley Centers director for five years, and currently serves as the centers chief scientist. He also holds an academic appointment at MIT as a Professor of the Practice in the Department of Biology.
From 1982 to 2003, Scolnick served as president of Merck Research Laboratories; executive vice president for science and technology at Merck & Co., Inc.; executive director and vice president in the department of virus and cell biology and senior vice president for basic research at Merck Research Laboratories.
Prior to joining Merck, he worked at the National Cancer Institute where he demonstrated the cellular origin of sarcoma virus oncogenes in mammals and defined specific genes that cause human cancer. He also worked at the National Heart Institute where his work defined the stop signals in the genetic code and the biochemical mechanism that produces the stops.
Scolnick is an elected member of the National Academy of Sciences, the American Academy of Arts and Sciences, and the Institute of Medicine. Among his many other academic honors, he was selected as Regents Lecturer, University of California at Berkeley, and as Frank H.T. Rhodes Class of 56 University Professor at Cornell University. He was also appointed to the Board of Visitors at the University of Pittsburgh School of Medicine.
He served on the Board of Directors of Merck & Co., Inc. from 1997 to 2002; the Board of Councillors for the National Institute of Mental Health from 1998 to 2002; and the FDA Science Board from 2000 to 2002. He currently is a consultant for Clarus Ventures.
Scolnick holds an A.B. from Harvard College and an M.D. from Harvard University Medical School.
There is no fee for this seminar. TO REGISTER …CLICK HERE,
Questions may be addressed to Kim MacAlister, Pepper Law
Add to my Outlook Calendar
Add to my iCal Calendar
Add to my Google Calendar
http://www.google.com/calendar/event?action=TEMPLATE&text=Apr 21 Pepper Hamilton Life Sciences Speaker Series&dates=20160421T120000Z/20160421T133000Z&sprop=null&details=Details: https://www.123signup.com/event?id=ngqjb&location=Boston Marriott Cambridge, Cambridge, MA